![Karl Deres](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Dr. Karl Deres will join BioMedPartners as a new Venture Partner and will support the representation office in Munich.
Dr. Deres is a biochemist with a strong background in the pharmaceutical industry as well as broad operational expertise and experience in the biotech sector.
Dr. Deres worked for more than 15 years for Bayer Schering Pharma and Intervet Schering Plough.
In 2007, he founded DPC Pharma Consulting, an advisory company offering services in the pharmaceutical/biotech industry, including interim management in the fields of business & strategic
corporate development, clinical & regulatory aspects as well as R&D management.
Karl Deres active positions
| Companies | Position | Start |
|---|---|---|
BioMedPartners AG
 BioMedPartners AG Investment ManagersFinance BioMedPartners invests in companies located in Switzerland, Germany and neighboring Western Europe. The firm focuses on biotechnology, emerging pharmaceutical, medical technology and other healthcare-related industries such as diagnostics or platform technologies. It participates in seed and early stage capital transactions. It also makes follow-on investments and acts a lead or co-lead investor. | Private Equity Investor | 13/01/2010 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
13
1st degree connections
1
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
BioMedPartners AG
BioMedPartners AG Investment ManagersFinance BioMedPartners invests in companies located in Switzerland, Germany and neighboring Western Europe. The firm focuses on biotechnology, emerging pharmaceutical, medical technology and other healthcare-related industries such as diagnostics or platform technologies. It participates in seed and early stage capital transactions. It also makes follow-on investments and acts a lead or co-lead investor. | Finance |
- Stock Market
- Insiders
- Karl Deres
